Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Mahla, E; Höchtl, T; Prüller, F; Freynhofer, MK; Huber, K.
Platelet function: new drugs, new assays : Possible impacts on operative medicine?
Anaesthesist. 2012; 61(6):483-496
Doi: 10.1007/s00101-012-2041-1
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Mahla Elisabeth
- Co-Autor*innen der Med Uni Graz
-
Prüller Florian
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Dual antiplatelet therapy with aspirin and a P2Y12 receptor blocker is a well-established strategy to prevent thrombotic complications in patients with acute coronary syndromes (ACS) and after percutaneous coronary interventions (PCI). Current practice guidelines for antiplatelet therapy advocate a 1 to 12-month dual antiplatelet therapy after bare metal stent PCI and an up to 12-month dual antiplatelet therapy after PCI in patients with ACS and drug-eluting stent PCI. Premature withdrawal of dual antiplatelet therapy carries a substantial risk of stent thrombosis but perioperative continuation of dual antiplatelet therapy is associated with an increased risk of bleeding, particularly in patients treated with the new potent drugs prasugrel and ticagrelor. Based on the various available assays, the lack of validated cut-offs and the disappointing results of targeted antiplatelet therapy as demonstrated by the GRAVITAS trial, current guidelines of international societies recommend platelet function testing only for selected high risk patients despite the known association between clopidogrel low responsiveness and ischemic events. However, for individual patients taking clopidogrel, platelet function monitoring may be considered to safely shorten the preoperative waiting period, to assess the risk of bleeding and transfusion and to initiate specific therapy in bleeding patients.
- Find related publications in this database (using NLM MeSH Indexing)
-
Adenosine - adverse effects
-
Angioplasty, Balloon, Coronary -
-
Humans -
-
Piperazines - adverse effects
-
Platelet Aggregation -
-
Platelet Aggregation Inhibitors - adverse effects
-
Platelet Function Tests -
-
Point-of-Care Systems -
-
Postoperative Complications - prevention & control
-
Postoperative Hemorrhage - chemically induced
-
Practice Guidelines as Topic -
-
Predictive Value of Tests -
-
Stents -
-
Thiophenes - adverse effects
-
Thrombosis - prevention & control
-
Ticlopidine - adverse effects
- Find related publications in this database (Keywords)
-
Surgery
-
Bleeding
-
Prasugrel
-
Ticagrelor
-
Platelet function tests